Sponsor Pipeline

Rapamycin Holdings Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06950385 Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis Familial Adenomatous Polyposis (FAP) Recruiting
Phase 2
NCT04230499 Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under… Familial Adenomatous Polyposis Active, Not Recruiting
Get alerts when Rapamycin Holdings Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free